We understand that everyone's cancer experience is unique. Our experts use the latest technology, innovative treatments and research to meet the needs of each patient and family.
Clinical Trials Available at Virginia Piper Cancer Institute
For further information regarding the clinical trials, please speak with your doctor or contact the Virginia Piper Cancer Institute Research Department at 612-863-8716.
Please note that while our goal is to keep this Web site as current as possible, it is possible that the status of a study may be different than what is reflected below. Please contact the Virginia Piper Cancer Institute Research Department for further information.
DCVax-Brain 020221 - currently cannot enroll new patients
A Phase II Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme
VPJT0401
Mechanisms of Glioma Invasion of the Brain
VPWM0701
Tissue Microarrary for Validation of a New Immunohistochemical Panel Pitutary Adenoma
EMD 121974-011
Cilengitide for subjects with newly diagnosed glioblastoma multiforme and methylated MGMT gene promoter - a multicenter, open-label, controlled Phase III study, testing cilengitide in combination with standard treatment (temozolomide with concomitant radiation therapy, followed by temozolomide maintenance therapy) versus standard treatment alone (CENTRIC).